Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events-Reference-Cited by-同舟云学术

Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events

Published:2021-03 Issue: Volume:320 Page:31-37
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Klingenberg Roland,Aghlmandi Soheila^ORCID,Gencer Baris,Nanchen David^ORCID,Räber Lorenz,Carballo David,Carballo Sebastian,Stähli Barbara E.,Landmesser Ulf,Rodondi Nicolas,Mach François,Windecker Stephan,Bucher Heiner C.,von Eckardstein Arnold,Lüscher Thomas F.,Matter Christian M.^ORCID

Funder

Schweizerische Herzstiftung

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes;Klingenberg;Eur. Heart J.,2017

2. From focal lipid storage to systemic inflammation: JACC review topic of the week;Libby;J. Am. Coll. Cardiol.,2019

3. Antiinflammatory therapy with canakinumab for atherosclerotic disease;Ridker;N. Engl. J. Med.,2017

4. Low-dose methotrexate for the prevention of atherosclerotic events;Ridker;N. Engl. J. Med.,2019

5. Efficacy and safety of low-dose colchicine after myocardial infarction;Tardif;N. Engl. J. Med.,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Residual inflammatory risk and vulnerable plaque in the carotid artery in patients with ischemic stroke;Frontiers in Neurology;2024-04-24

2. Comparison of interleukin-6 and high-sensitivity C-reactive protein for cardiovascular risk assessment: Findings from the MESA study;Atherosclerosis;2024-03

3. Relationship of comorbidity and platelet function in patients with unstable angina;Translational Medicine;2023-10-17

4. History of peripheral artery disease and cardiovascular risk of real-world patients with acute coronary syndrome: Role of inflammation and comorbidities;International Journal of Cardiology;2023-07

5. Post-PCI Risk Assessment by Inflammation Activity According to Disease Acuity and Time from Procedure;Thrombosis and Haemostasis;2023-01-12